# Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

> **NCT06258486** · PHASE4 · UNKNOWN · sponsor: **Kaiser Permanente** · enrollment: 100 (estimated)

## Conditions studied

- Lymphocele
- Prostate Cancer

## Interventions

- **DRUG:** ICG injection
- **OTHER:** Non-Injection/Control
- **PROCEDURE:** Prostatectomy with pelvic lymph node dissection

## Key facts

- **NCT ID:** NCT06258486
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258486, "Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06258486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*